Precirix NV
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $56M
Investors
- 9
About Precirix NV
Founded in 2014, Precirix NV is headquartered in Brussels, Belgium, and specializes in precision radiopharmaceuticals.Precirix is focused on developing precision radiopharmaceuticals aimed at improving cancer treatment outcomes. The company’s lead product candidate targets Fibroblast Activation Protein (FAP) and utilizes camelid single-domain antibodies (sdAb) labeled with radiometals, currently transitioning into clinical trials. This innovative approach positions Precirix to potentially introduce the first-in-class alpha-emitting targeted radiotherapy specifically for FAP, a pan-tumor target. The company is also engaged in ongoing research involving various isotopes, linker technology, and combination therapies to broaden its product platform.Precirix generates revenue through partnerships and collaborations in the biotechnology and pharmaceutical sectors. The company engages in B2B transactions with healthcare institutions and research organizations that require advanced cancer treatment solutions. This includes bringing additional novel radiopharmaceuticals to clinical settings and further developing their platform to generate new product candidates, linkers, and CMC processes. Precirix is also aiming to expand its market presence in Europe and North America, targeting specific oncology markets. The company’s strategic initiatives are designed to enhance its product offerings and support its mission in the oncology sector.
Who invested in Precirix NV
9 investors across 2 rounds
See all investors in Precirix NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Precirix NV
Who invested in Precirix NV?
Precirix NV has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Precirix NV raised?
Precirix NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Precirix NV last raise money?
Precirix NV's most recent round on record is a Series B, in Mar 2022.
What does Precirix NV do?
Founded in 2014, Precirix NV is headquartered in Brussels, Belgium, and specializes in precision radiopharmaceuticals.
Where is Precirix NV headquartered?
Precirix NV is headquartered in Brussels, Belgium.
Which VCs invest in companies like Precirix NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Precirix NV's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Precirix NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.